HIF1A and liver cancer: To investigate the effects of TCF12 and HIF-1α on tube formation and drug sensitivity in liver cancer vascular ECs, we examined three groups: a control group, a TCF12 shRNA group, and a TCF12 shRNA plus HIF-1α group.